Related Experiment Videos

Blood platelet function in patients with obliterative arteriosclerosis of the lower limbs

A Bodzenta-Lukaszyk1, K Krupiński, S Dabrowski

  • 1Department of Haemtology, Medical School Bialystok, Poland.

Folia Haematologica (Leipzig, Germany : 1928)
|January 1, 1988
PubMed

Insights

Patients with lower limb obliterative arteriosclerosis show platelet hyperfunction. This is evidenced by increased sensitivity to ADP and PAF, higher Beta-thromboglobulin (Beta-TG) and Thromboxane B2 (TXB2) levels, and lower 6-keto-PGF1 alpha and cyclic AMP.

Area of Science:

  • Vascular Biology
  • Hematology
  • Biochemistry

Background:

  • Obliterative arteriosclerosis of the lower limbs is a condition affecting blood circulation.
  • Platelet activation plays a crucial role in thrombotic and vascular diseases.
  • Understanding platelet behavior in arteriosclerosis is vital for disease management.

Purpose of the Study:

  • To investigate specific markers of platelet activation in patients with lower limb obliterative arteriosclerosis.
  • To assess platelet sensitivity to agonists like ADP and PAF.
  • To quantify levels of key platelet-related molecules.

Main Methods:

  • Measurement of platelet aggregation induced by ADP, AA, and PAF.
  • Quantification of Beta-thromboglobulin (Beta-TG) and Thromboxane B2 (TXB2) levels.
  • Assay of 6-keto-PGF1 alpha and cyclic AMP levels in patient blood samples.

Main Results:

  • Patients exhibited heightened platelet sensitivity to ADP and PAF.
  • Elevated levels of Beta-TG and TXB2 were observed.
  • Decreased levels of 6-keto-PGF1 alpha and cyclic AMP were detected, indicating platelet hyperfunction.

Conclusions:

  • Patients with lower limb obliterative arteriosclerosis demonstrate significant platelet hyperfunction.
  • These findings support the broader concept of atherosclerosis involving widespread functional cellular alterations.

Related Concept Videos